CDC Advisory Committee for Kids 5-11 | FULL MEETING

The Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel today unanimously recommended Pfizer’s COVID vaccine for children 5 to 11, despite concerns raised during the meeting about Pfizer’s clinical data, the fact that children who previously acquired natural immunity to COVID were included in clinical trials and evidence showing COVID poses little risk to children.

On November 2, 2021 an international research journal (The BMJ) published an entry detailing a researchers report of data integrity issues with Pfizer’s vaccine trial, including falsified data, unblinded patients, inadequate training, and deliberate delays for following up on adverse events reported during phase III of the clinical trial. https://www.bmj.com/content/bmj/375/bmj.n2635.full.pdf